Chemed Cash Flow from Operating Activities 2010-2024 | CHE

Chemed annual/quarterly cash flow from operating activities history and growth rate from 2010 to 2024. Cash flow from operating activities can be defined as a company's cash flows from operations.
  • Chemed cash flow from operating activities for the quarter ending December 31, 2024 was $0.417B, a 26.4% increase year-over-year.
  • Chemed cash flow from operating activities for the twelve months ending December 31, 2024 was $0.917B, a 13.83% increase year-over-year.
  • Chemed annual cash flow from operating activities for 2024 was $0.417B, a 26.4% increase from 2023.
  • Chemed annual cash flow from operating activities for 2023 was $0.33B, a 6.59% increase from 2022.
  • Chemed annual cash flow from operating activities for 2022 was $0.31B, a 0.42% increase from 2021.
Chemed Annual Cash Flow Ops
(Millions of US $)
2024 $417
2023 $330
2022 $310
2021 $309
2020 $489
2019 $301
2018 $287
2017 $162
2016 $135
2015 $172
2014 $110
2013 $151
2012 $132
2011 $174
2010 $86
2009 $161
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $9.006B $2.431B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.777B 18.97
DaVita (DVA) United States $12.238B 15.61
Encompass Health (EHC) United States $10.200B 22.86
Option Care Health (OPCH) United States $5.740B 27.52
Elanco Animal Health (ELAN) United States $5.213B 11.54
RadNet (RDNT) United States $3.681B 78.92
Amedisys (AMED) United States $3.039B 21.49
LifeStance Health (LFST) United States $2.561B 0.00
Addus HomeCare (ADUS) United States $1.797B 20.82
Astrana Health (ASTH) United States $1.554B 34.84
U.S Physical Therapy (USPH) United States $1.099B 28.05
Aveanna Healthcare Holdings (AVAH) United States $1.057B 0.00
Pennant (PNTG) United States $0.866B 34.93
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Bioqual (BIOQ) United States $0.051B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00